Clinical Trials Directory

Trials / Completed

CompletedNCT01425788

Comparison of Different Up-dosing Schedules With Osiris Phleum Pratense

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
236 (actual)
Sponsor
ALK-Abelló A/S · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this trial is to investigate the tolerability of Osiris Phleum pratense used with 2 simplified up-dosing schedules compared to the up-dosing schedule used in current practice.

Conditions

Interventions

TypeNameDescription
BIOLOGICALOsiris Phleum pratense
BIOLOGICALOsiris Phleum pratense
BIOLOGICALOsiris Phleum pratense

Timeline

Start date
2011-08-01
Primary completion
2011-11-01
Completion
2012-02-01
First posted
2011-08-30
Last updated
2015-06-26

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT01425788. Inclusion in this directory is not an endorsement.